Media

Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)

Strongbridge Biopharma plc Announces Publication of Diabetes Subgroup Analysis from Phase 3 SONICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in Frontiers in Endocrinology

Fusion Pharmaceuticals Announces Closing Of Acquisition Of IPN-1087, A Small Molecule Targeting NTSR1, From Ipsen

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Increase of number of shares and votes in Vicore Pharma

Number of shares and votes in Oncopeptides

Nordic Nanovector ASA publishes 2020 Annual Report

Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results And Business Update

Nordic Nanovector ASA – Commencement of the subscription period in the repair offering

Orexo publishes Annual Report for 2020